Search

Your search keyword '"Needham, Merrilee"' showing total 12 results
Start Over Author "Needham, Merrilee" Publisher wiley
12 results on '"Needham, Merrilee"'

2. Provisional practice recommendation for the management of myopathy in VCP ‐associated multisystem proteinopathy

Author

Roy, Bhaskar, primary, Peck, Allison, additional, Evangelista, Teresinha, additional, Pfeffer, Gerald, additional, Wang, Leo, additional, Diaz‐Manera, Jordi, additional, Korb, Manisha, additional, Wicklund, Matthew P., additional, Milone, Margherita, additional, Freimer, Miriam, additional, Kushlaf, Hani, additional, Villar‐Quiles, Rocio‐Nur, additional, Stojkovic, Tanya, additional, Needham, Merrilee, additional, Palmio, Johanna, additional, Lloyd, Thomas E., additional, Keung, Benison, additional, Mozaffar, Tahseen, additional, Weihl, Conrad Chris, additional, and Kimonis, Virginia, additional

Published
2023
Full Text
View/download PDF

6. Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial

Author

Coudert, Jerome D, primary, Slater, Nataliya, additional, Sooda, Anuradha, additional, Beer, Kelly, additional, Lim, Ee Mun, additional, Boyder, Conchita, additional, Zhang, Rui, additional, Mastaglia, Frank L, additional, Learmonth, Yvonne C, additional, Fairchild, Timothy J, additional, Yeap, Bu B, additional, and Needham, Merrilee, additional

Published
2022
Full Text
View/download PDF

7. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations

Author

Sue, Carolyn M., primary, Balasubramaniam, Shanti, additional, Bratkovic, Drago, additional, Bonifant, Catherine, additional, Christodoulou, John, additional, Coman, David, additional, Crawley, Karen, additional, Edema‐Hildebrand, Fabienne, additional, Ellaway, Carolyn, additional, Ghaoui, Roula, additional, Kava, Maina, additional, Kearns, Lisa S., additional, Lee, Joy, additional, Liang, Christina, additional, Mackey, David A., additional, Murray, Sean, additional, Needham, Merrilee, additional, Rius, Rocio, additional, Russell, Jacqui, additional, Smith, Nicholas J.C., additional, Thyagarajan, Dominic, additional, and Wools, Christine, additional

Published
2021
Full Text
View/download PDF

11. Evaluation of an Australian neurological nurse-led model of postdischarge care

Author

<p>Department of Health, Western Australia</p>, Pugh, Judith Dianne, McCoy, Kathleen, Needham, Merrilee, Jiang, Leanne, Giles, Margaret, McKinnon, Elizabeth, Heine, Kym, <p>Department of Health, Western Australia</p>, Pugh, Judith Dianne, McCoy, Kathleen, Needham, Merrilee, Jiang, Leanne, Giles, Margaret, McKinnon, Elizabeth, and Heine, Kym

Abstract

Pugh, J. D., McCoy, K., Needham, M., Jiang, L., Giles, M., McKinnon, E., & Heine, K. (2021). Evaluation of an Australian neurological nurse‐led model of postdischarge care. Health and Social Care in the Community. Advance online publication. https://doi.org/10.1111/hsc.13498

12. Amyotrophic lateral sclerosis established as a multistep process across phenotypes.

Author

Ziser L, van Eijk RPA, Kiernan MC, McRae A, Henderson RD, Schultz D, Needham M, Mathers S, McCombe P, Talman P, and Vucic S

Abstract

Background and Purpose: Given the accepted multistep process of disease causation in amyotrophic lateral sclerosis (ALS), the present study was undertaken to determine the number of steps required for disease onset across each of the ALS phenotypes., Methods: Clinical and demographic data were prospectively accumulated using the Australian Motor Neurone Disease Registry (2005-2016), and age-specific incidence rates were calculated. Poisson regression was utilized to assess the relationship between log age-specific incidence and log age of onset, with McFadden's R 2 used to assess the goodness of fit of the model., Results: In total, 2647 ALS patients were included, with mean disease-onset age being 62.2 ± 12.1 years. A linear relationship between log incidence and log age was established across ALS phenotypes, with variable slope estimates: bulbar 5.1 (95% confidence interval [CI] 4.6-5.6); cervical 2.7 (95% CI 2.3-3.0); lumbar 3.5 (95% CI 3.2-3.9); flail arm 4.7 (95% CI 3.9-5.5); flail leg 3.6 (95% CI 2.6-4.5); primary lateral sclerosis 2.7 (95% CI 1.8-3.7). Slope estimates were significantly higher in the bulbar compared to the cervical, lumbar and primary lateral sclerosis phenotypes. McFadden's R 2 values were >0.4 for all phenotypes indicating excellent model fit., Discussion: A multistep process has been established across all ALS phenotypes with variable slope estimates, suggesting that the number of steps to develop disease is different across clinical presentations. Identification of mechanisms underlying slope estimate variability could exert pathophysiological significance., (© 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results